Andon Health Company Limited operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Andon Health Company Limited with three other companies in this sector in CHINA : Guangzhou Improve Medical Instruments Company Limited (2019 sales of 575.06 million Chinese Renmimbi [US$87.50 million] of which 96% was Medical Industry), Jiangxi Sanxin Medtec Co Ltd (721.67 million Chinese Renmimbi [US$109.81 million] of which 99% was Medical Equipment), and Beijing Bohui Innovation Biotechnology Co Ltd (628.34 million Chinese Renmimbi [US$95.61 million] of which 51% was Diagnose).

Sales Analysis. During the year ended December of 2019, sales at Andon Health Company Limited were 706.28 million Chinese Renmimbi (US$107.47 million). This is an increase of 25.3% versus 2018, when the company's sales were 563.88 million Chinese Renmimbi. Sales of Other Income saw an increase that was more than double the company's growth rate: sales were up 145.6% in 2019, from 13.50 million Chinese Renmimbi to 33.15 million Chinese Renmimbi.